Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challenge
This study explores a dual expression vector system for delivering prokaryotic and eukaryotic antigens to improve conventional vaccination strategies. To enhance immune protection against H9N2 avian influenza virus (AIV), which threatens poultry and humans, we used the previously constructed pJHL270...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Poultry Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0032579124011805 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832591816889729024 |
---|---|
author | Ram Prasad Aganja In-Shik Kim Hyun-Jin Tae John Hwa Lee |
author_facet | Ram Prasad Aganja In-Shik Kim Hyun-Jin Tae John Hwa Lee |
author_sort | Ram Prasad Aganja |
collection | DOAJ |
description | This study explores a dual expression vector system for delivering prokaryotic and eukaryotic antigens to improve conventional vaccination strategies. To enhance immune protection against H9N2 avian influenza virus (AIV), which threatens poultry and humans, we used the previously constructed pJHL270 and pJHL305 plasmids with the Ptrc and CMV promoters to stimulate MHC class II and I responses through exogenous and endogenous antigenic presentation. Salmonella Gallinarum (SG), a delivery vector, was engineered to have defective lipopolysaccharide structures through lon, pagL, and rfaL deletion. It demonstrated a safety profile with lower induction of inflammatory cytokines than the wild-type strain. Bioinformatics tools predicted that the HA1 and M2e sequences, which were designed as consensus sequences of South Korean strains (2000–2021), would have high antigenicity and favorable structures. In vitro expression of the vaccine constructs was validated by western blotting. Birds immunized with attenuated SG harboring pJHL270 (JOL3025) or pJHL305 (JOL3027) containing HA-M2e showed significant increases in serum IgY and mucosal IgA antibodies, indicating strong humoral and mucosal immune responses, comparable with inactivated commercial vaccine. Post-immunization, we found a substantial rise in the hemagglutination inhibition titer, suggesting effective prevention of viral attachment and robust cell-mediated immunity, with a 1.96-fold and 2.80-fold increase in CD4+ and CD8+ T cells, respectively, for JOL3025 and a 1.75-fold and 2.49-fold increase for JOL3027. Furthermore, MHC class I and II expression increased 1.35-fold and 1.63-fold, for JOL3025, and 1.61-fold and 1.68-fold, respectively, for JOL3027. The IL-4 and IFN-γ levels were elevated, indicating a balanced Th-1 and Th-2 response. Post-challenge, birds immunized with vaccine candidates or the commercial vaccine exhibited minimal to no clinical signs, reduced lesions, lower lung viral titers, and negligible impacts on egg production compared to controls. In conclusion, both plasmids successfully delivered HA1-M2e immunogens through the engineered SG strains, eliciting strong humoral, mucosal, and cell-mediated immune responses and co-stimulating MHC class I and II antigen presentation pathways to provide effective protection against H9N2 AIV with minimal adverse effects. |
format | Article |
id | doaj-art-07b4a9ba90b346f0a6c7cdcaf563f4e5 |
institution | Kabale University |
issn | 0032-5791 |
language | English |
publishDate | 2025-01-01 |
publisher | Elsevier |
record_format | Article |
series | Poultry Science |
spelling | doaj-art-07b4a9ba90b346f0a6c7cdcaf563f4e52025-01-22T05:40:39ZengElsevierPoultry Science0032-57912025-01-011041104602Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challengeRam Prasad Aganja0In-Shik Kim1Hyun-Jin Tae2John Hwa Lee3College of Veterinary Medicine, Jeonbuk National University, Iksan Campus, Iksan 54596, Republic of Korea; College of Veterinary Medicine and Institute of Animal Transplantation, Jeonbuk National University, Campus, Iksan 54596, Republic of KoreaCollege of Veterinary Medicine and Institute of Animal Transplantation, Jeonbuk National University, Campus, Iksan 54596, Republic of KoreaCollege of Veterinary Medicine and Institute of Animal Transplantation, Jeonbuk National University, Campus, Iksan 54596, Republic of KoreaCollege of Veterinary Medicine, Jeonbuk National University, Iksan Campus, Iksan 54596, Republic of Korea; College of Veterinary Medicine and Institute of Animal Transplantation, Jeonbuk National University, Campus, Iksan 54596, Republic of Korea; Corresponding author.This study explores a dual expression vector system for delivering prokaryotic and eukaryotic antigens to improve conventional vaccination strategies. To enhance immune protection against H9N2 avian influenza virus (AIV), which threatens poultry and humans, we used the previously constructed pJHL270 and pJHL305 plasmids with the Ptrc and CMV promoters to stimulate MHC class II and I responses through exogenous and endogenous antigenic presentation. Salmonella Gallinarum (SG), a delivery vector, was engineered to have defective lipopolysaccharide structures through lon, pagL, and rfaL deletion. It demonstrated a safety profile with lower induction of inflammatory cytokines than the wild-type strain. Bioinformatics tools predicted that the HA1 and M2e sequences, which were designed as consensus sequences of South Korean strains (2000–2021), would have high antigenicity and favorable structures. In vitro expression of the vaccine constructs was validated by western blotting. Birds immunized with attenuated SG harboring pJHL270 (JOL3025) or pJHL305 (JOL3027) containing HA-M2e showed significant increases in serum IgY and mucosal IgA antibodies, indicating strong humoral and mucosal immune responses, comparable with inactivated commercial vaccine. Post-immunization, we found a substantial rise in the hemagglutination inhibition titer, suggesting effective prevention of viral attachment and robust cell-mediated immunity, with a 1.96-fold and 2.80-fold increase in CD4+ and CD8+ T cells, respectively, for JOL3025 and a 1.75-fold and 2.49-fold increase for JOL3027. Furthermore, MHC class I and II expression increased 1.35-fold and 1.63-fold, for JOL3025, and 1.61-fold and 1.68-fold, respectively, for JOL3027. The IL-4 and IFN-γ levels were elevated, indicating a balanced Th-1 and Th-2 response. Post-challenge, birds immunized with vaccine candidates or the commercial vaccine exhibited minimal to no clinical signs, reduced lesions, lower lung viral titers, and negligible impacts on egg production compared to controls. In conclusion, both plasmids successfully delivered HA1-M2e immunogens through the engineered SG strains, eliciting strong humoral, mucosal, and cell-mediated immune responses and co-stimulating MHC class I and II antigen presentation pathways to provide effective protection against H9N2 AIV with minimal adverse effects.http://www.sciencedirect.com/science/article/pii/S0032579124011805H9N2Dual expression systemSalmonellaViral titerCell-Mediated response |
spellingShingle | Ram Prasad Aganja In-Shik Kim Hyun-Jin Tae John Hwa Lee Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challenge Poultry Science H9N2 Dual expression system Salmonella Viral titer Cell-Mediated response |
title | Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challenge |
title_full | Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challenge |
title_fullStr | Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challenge |
title_full_unstemmed | Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challenge |
title_short | Expression and delivery of HA1-M2e antigen using an innovative attenuated Salmonella–mediated delivery system confers promising protection against H9N2 avian influenza challenge |
title_sort | expression and delivery of ha1 m2e antigen using an innovative attenuated salmonella mediated delivery system confers promising protection against h9n2 avian influenza challenge |
topic | H9N2 Dual expression system Salmonella Viral titer Cell-Mediated response |
url | http://www.sciencedirect.com/science/article/pii/S0032579124011805 |
work_keys_str_mv | AT ramprasadaganja expressionanddeliveryofha1m2eantigenusinganinnovativeattenuatedsalmonellamediateddeliverysystemconferspromisingprotectionagainsth9n2avianinfluenzachallenge AT inshikkim expressionanddeliveryofha1m2eantigenusinganinnovativeattenuatedsalmonellamediateddeliverysystemconferspromisingprotectionagainsth9n2avianinfluenzachallenge AT hyunjintae expressionanddeliveryofha1m2eantigenusinganinnovativeattenuatedsalmonellamediateddeliverysystemconferspromisingprotectionagainsth9n2avianinfluenzachallenge AT johnhwalee expressionanddeliveryofha1m2eantigenusinganinnovativeattenuatedsalmonellamediateddeliverysystemconferspromisingprotectionagainsth9n2avianinfluenzachallenge |